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The generation of pancreas, liver, and intestine from
a common pool of progenitors in the foregut endo-
derm requires the establishment of organ bound-
aries. How dorsal foregut progenitors activate
pancreatic genes and evade the intestinal lineage
choice remains unclear. Here, we identify Pdx1
and Sox9 as cooperative inducers of a gene regula-
tory network that distinguishes the pancreatic from
the intestinal lineage. Genetic studies demonstrate
dual and cooperative functions for Pdx1 and Sox9
in pancreatic lineage induction and repression of
the intestinal lineage choice. Pdx1 and Sox9 bind
to regulatory sequences near pancreatic and intesti-
nal differentiation genes and jointly regulate their
expression, revealing direct cooperative roles for
Pdx1 and Sox9 in gene activation and repression.
Our study identifies Pdx1 and Sox9 as important
regulators of a transcription factor network that ini-
tiates pancreatic fate and sheds light on the gene
regulatory circuitry that governs the development
of distinct organs from multi-lineage-competent
foregut progenitors.
INTRODUCTION
During mammalian development, naive endodermal progeni-
tors are directed toward different organ fates, including lung,
pancreas, liver, and intestine. At developmental junctures, multi-
potent progenitorsmust be allocated to different lineages, exem-
plified by progenitors in the foregut endoderm, which give rise
to pancreas, stomach, duodenum, liver, and the hepatobiliary
system. Organ lineage choices are initiated by cross-repressive326 Cell Reports 13, 326–336, October 13, 2015 ª2015 The Authorsinteractions between transcription factors (TFs) driving alterna-
tive lineage programs, followed by feed-forward induction of
additional TFs to further execute the differentiation process
(Holmberg and Perlmann, 2012). A large body of work has iden-
tified numerous TFs that are required for the early development
of individual organs, in particular, the pancreas and liver (Sey-
mour and Sander, 2011; Zaret, 2008). Despite these significant
advances, it is still poorly understood which regulatory networks
induce specific organ fates and howorgan boundaries are estab-
lished in the foregut endoderm. Identifying the mechanisms
responsible for specifying individual organ fates is important
for devising cell reprogramming strategies, which are still lacking
for ex vivo production of pancreatic cells.
The pancreas arises as two buds on opposing sides of the
gut tube at the boundary between the stomach and duodenum,
the most rostral portion of the intestine (Shih et al., 2013).
The anatomical location of the pancreas implies that an organ
boundary must be established that distinguishes pancreatic
from stomach and intestinal progenitors. The TF Cdx2 is exclu-
sively expressed in intestinal epithelial cells, spanning the length
of the alimentary tract from the proximal duodenum to the distal
rectum. Cdx2 is essential for intestinal development and induces
intestinal epithelial differentiation by activating the transcription
of intestine-specific genes, such as MUC2, sucrase, and car-
bonic anhydrase I (Gao et al., 2009; Verzi et al., 2011). However,
the mechanisms preventing expansion of the Cdx2 expression
domain beyond the duodenal boundary in the foregut endoderm
remain undefined.
The TFs Pdx1, Foxa2, Mnx1 (Hb9), Onecut-1 (Hnf6), Prox1,
Tcf2, Gata4/Gata6, Sox9, and Ptf1a each play an important
role in early pancreas development, yet deletion of no single fac-
tor alone is sufficient to abrogate pancreatic lineage induction
(Carrasco et al., 2012; Harrison et al., 1999; Haumaitre et al.,
2005; Jacquemin et al., 2000; Kawaguchi et al., 2002; Lee
et al., 2005; Offield et al., 1996; Seymour et al., 2007; Wang
et al., 2005; Xuan et al., 2012). These observations imply either
Figure 1. Principal Component Analysis
for Expression of Transcription Factors in
Endodermal Cell Populations
(A) Experimental strategy for principal component
analysis of transcription factors in various endo-
dermal cell populations.
(B) Principal component (PC) analysis of the
expression values (RPKM) characterizing the
variance explained by transcription factors ex-
pressed in human embryonic stem cell (hESC)-
derived populations and primary human cells.
Each vector emanating from the origin represents
an individual gene. Each dot represents a sample,
and each color represents the type of sample.that the inducer of the pancreatic fate remains to be identified or
that the pancreatic fate is specified through a cooperative mech-
anism involving multiple TFs.
Combining genetic, cistrome, and transcriptome analysis, we
here identify the TFs Pdx1 and Sox9 as cooperative inducers of
the pancreatic lineage. The combined inactivation of Pdx1 and
Sox9 leads to an intestinal fate conversion of the pre-pancreatic
domain, illustrated by expansion of the field of Cdx2 expression.
Conversely, ectopic expression of Sox9 in intestinal progenitors
is sufficient to induce Pdx1 and repress Cdx2. At a mechanistic
level, we show that Pdx1 and Sox9 function as direct and coop-
erative activators of pancreatic genes and repressors of intesti-
nal lineage regulators. Together, these findings shed light on the
transcriptional mechanisms that induce the pancreatic fate and
establish the pancreatic-to-intestinal organ boundary.
RESULTS
Pdx1 and Sox9 Cooperatively Induce the Pancreatic
Lineage Program
To identify TFs most closely associated with pancreatic lineage
induction, we compared expression levels of TFs represented
in the RNA-seq data from pancreatic progenitor cells and closely
related endodermal cell populations. These comprised human
embryonic stem cell (hESC)-derived definitive endoderm, gut
tube progenitors, posterior foregut, pancreatic progenitors,
hepatic progenitors, and endocrine cells as well as primary hu-
man fetal pancreatic anlagen and primary cadaver pancreatic
islets (Figure 1A). Principal component analysis of TF expression
data clustered the different cell populations by developmental
proximity, effectively reconstructing the dynamics of endo-
dermal development and underscoring the importance of TF
levels in successfully delineating these cell types (Figure 1B).
Two TFs, PDX1 and SOX9, most strongly distinguished pancre-
atic progenitors from other cell populations (Figure 1B), suggest-
ing possible cooperative roles for PDX1 and SOX9 in pancreatic
lineage specification.
First, to define the domains of Pdx1 and Sox9 expression
during pancreatic specification, we performed co-immunofluo-Cell Reports 13, 326–336,rescence staining for Pdx1 and Sox9
together with the anterior foregut marker
Sox2 or the mid/hindgut marker Cdx2,
respectively, at embryonic day (E) 8.75(15–17 somites). The Sox2+ domain, fromwhich the stomach de-
velops (McCracken et al., 2014; Sherwood et al., 2009), formed
a boundary with both the Pdx1+ and Sox9+ domains (Figures
2A–2A00). Very few cells co-expressing Sox2, Pdx1, and Sox9
were observed at this boundary (Figures 2A–2A00). Cells in the
presumptive proximal duodenum expressed high levels of
Cdx2 and Sox9 (Figures 2B–2B00). In contrast to Sox9, which
spanned the proximal duodenal and pre-pancreatic domains,
Pdx1 was restricted to the pre-pancreatic domain (Figures 2B
and 2B0). At the boundary between the duodenal and pre-
pancreatic domains, we observed a transition from a Cdx2high
to a Cdx2low state (Figures 2B and 2B00, dashed line; Movie
S1). Consistent with previous studies (McCracken et al., 2014),
Cdx2 was largely absent from the pancreatic buds (Figure 2C),
showing that Cdx2 is gradually excluded from the pancreatic
domain.
To determine the fate of Sox9- or Pdx1-expressing cells in the
foregut endoderm, we performed lineage tracing in embryos car-
rying the Rosa26mTomato/mGFP (R26mT/mG) reporter allele and an
inducible form of Cre-recombinase, CreER, driven by either
Sox9 or Pdx1 regulatory sequences. In these mice, tamoxifen
administration to pregnant dams turns off constitutive expres-
sion of membrane-targeted Tomato (mT) and induces heritable
expression of membrane-targeted GFP (mGFP), permitting re-
combined cells and their progeny to be traced bymGFP labeling.
Tamoxifen administration at E8.0 resulted in labeling of the
pancreatic epithelium in R26mT/mG;Pdx1-CreER (Figure 2D) and
R26mT/mG;Sox9-CreER (Figure 2E) embryos at E10.5. Consistent
with the incomplete segregation of the Cdx2+ and Pdx1+/Sox9+
domains at E8.75 (Figures 2B–2B00 and 2C), mGFP labeling was
also observed in scattered Cdx2+ cells of the proximal duo-
denum (Figures 2D and 2E). mGFP+ cells in the Sox2+ gastric
region were extremely rare (data not shown). Together, these
findings indicate that the pancreatic-to-stomach boundary
is largely established by E8.75, whereas the pancreatic and
duodenal domains separate gradually between E8.75 and E10.5.
Previous studies have shown that pancreatic outgrowth and
induction of a subset of early pancreatic markers still occur in
Pdx1 null mutants (Offield et al., 1996). Similarly, after conditionalOctober 13, 2015 ª2015 The Authors 327
Figure 2. Pdx1 and Sox9 Are Co-expressed
in the Pancreatic Domain in the Foregut
Endoderm
(A–B00) Immunofluorescence staining for Sox2,
Sox9, and Pdx1 (A–A00) and Cdx2, Sox9, and Pdx1
(B–B00) on embryonic sections at embryonic day (E)
8.75. The arrows in (A0) and (A00) and (B0) and (B00)
indicate Pdx1+/Sox9+ cells co-expressing Sox2
and Cdx2, respectively. The dashed line in (B)–(B00)
demarcates the transition from the presumptive
duodenal to the pre-pancreatic region. Fields
demarcated by white dashed boxes in (A0), (A00),
(B0), and (B00) are shown at higher magnification in
the same panels. Non-specific signal for Cdx2 is
evident in the foregut lumen (B and B00, asterisks)
due to antibody trapping.
(C) Immunofluorescence staining for Cdx2, Sox2,
and Pdx1 at E10.5.
(D and E) Dams carrying R26mT/mG embryos
expressing CreER driven by either the Pdx1 or
Sox9 regulatory sequences were injected with
tamoxifen at E8.0, embryos sectioned at E10.5,
and immunofluorescence staining performed for
Cdx2, Pdx1, and GFP. Recombined, membrane-
targeted GFP+ (mGFP+) cells trace to the pancre-
atic epithelium; scattered labeled cells are also detectable in the proximal duodenum in R26mT/mG;Pdx1-CreER (D) and R26mT/mG;Sox9-CreER (E) embryos.
dp, dorsal pancreas; vp, ventral pancreas; duo, duodenum; stom, stomach. Scale bars represent 50 mm.Sox9 inactivation with a Pdx1-Cre transgene pancreatic buds
evaginate (Seymour et al., 2007, 2012). However, since Pdx1-
Cre deletes Sox9 after the pancreatic program has been initi-
ated, it remains unclear whether Sox9 is necessary to initiate
the pancreatic program. To determine whether Sox9 is required
for pancreatic specification, we generated global Sox9 null
mutant embryos (Figures 3A and 3C). While hypoplastic, dorsal
and ventral pancreatic rudiments arise in Sox9 null embryos (Fig-
ures 3B, 3B0, 3D, and 3D0), showing that Sox9 is dispensable for
pancreatic fate assignment and outgrowth of the pancreatic
buds. Notably, although Pdx1 staining intensity is reduced,
Pdx1 is expressed in both dorsal and ventral pancreatic buds
of Sox9/ embryos (Figures 3B, 3B0, 3D, and 3D0), showing
that Sox9 is dispensable for Pdx1 induction. Similarly, we have
previously found Sox9 to be expressed in Pdx1-deficient dorsal
pancreatic progenitors at E10.5 (Seymour et al., 2012). Thus,
neither Pdx1 nor Sox9 is required for pancreas specification or
induction of the other’s expression.
Based on their early expression in pre-pancreatic cells, we
postulated that Sox9 and Pdx1 might function together and
induce the pancreatic lineage in a cooperative manner. To
test this, we generated mice lacking various combinations of
either one or two alleles of Pdx1, Sox9, or both. Since early
embryonic lethality of Sox9 null embryos precluded the anal-
ysis of compound mutants beyond E11.5 (Akiyama et al.,
2004), we employed a conditional Sox9 ablation strategy, using
the Foxa3-Cre transgenic line (Lee et al., 2005), which ablates
Sox9 efficiently in the gut tube by E9.5 (Sox9Dgut) (Figures
3E–3H00).
We next generated compound mutants carrying various
combinations of the Pdx1 null (Pdx1LacZko) and Sox9Dgut alleles
and visualized the dorsal and ventral pancreatic buds, antral
stomach, and duodenum by X-Gal staining for b-galactosidase328 Cell Reports 13, 326–336, October 13, 2015 ª2015 The Authors(b-gal) expressed from the Pdx1LacZko allele (Figures 3I and
3J). With progressive loss of Sox9 gene dosage (Sox9+/+ >
Sox9+/Dgut > Sox9Dgut/Dgut) on the Pdx1-heterozygous mutant
background, the pancreatic buds became increasingly hypo-
plastic (Figures 3I–3N). In E12.5 Pdx1+/;Sox9Dgut/Dgut embryos,
the dorsal pancreas was reduced to a severely hypoplastic
remnant, and the ventral pancreatic bud was undetectable
(Figure 3N; absent ventral pancreas denoted by asterisk).
Notably, the size of the ventral pancreatic bud was significantly
reduced in compound-heterozygous mutants (Figures 3K, 3L,
and 3U), which contrasted with the normal bud size seen in
embryos deficient for a single copy of either Pdx1 (Figures 3I
and 3J) or Sox9 (Seymour et al., 2008). This phenotype in
compound-heterozygous mutants demonstrates genetic inter-
action between Pdx1 and Sox9. The dorsal pancreas remnant
(the ventral pancreas is undetectable in Pdx1/ embryos;
Figure 3P, asterisk) became increasingly smaller with
decreasing Sox9 gene dosage on a Pdx1 null background (Fig-
ures 3O–3T) and was morphologically almost indiscernible in
compound-homozygous Pdx1/;Sox9Dgut/Dgut mutants (Fig-
ures 3S–3U). Combined, these genetic findings demonstrate
cooperative functions of Pdx1 and Sox9 in early pancreas
development.
To determine whether deletion of Pdx1 and Sox9 perturbs
induction of the pancreatic program, we next analyzed the
expression of early pancreatic markers in Pdx1;Sox9 compound
mutants. Confirming previous findings (Seymour et al., 2007,
2012), Sox9 expression was maintained in pancreatic rudiments
of Pdx1/ embryos at E10.5, and conversely, Pdx1was also ex-
pressed in Sox9Dgut/Dgut mutants (Figures S1A–S1N; note that
the truncated Pdx1 protein expressed from the Pdx1 null allele
is detected by the anti-Pdx1 antibody used). Immunofluores-
cence staining for Foxa2, Mnx1, Onecut-1, Tcf2, Gata4, and
Figure 3. Sox9 and Pdx1 Cooperatively
Specify the Pancreatic Lineage
(A and C) Confirmation of global Sox9 deletion by
whole mount immunofluorescence staining for
Sox9 of tail tips from control (A) and Sox9 null (C)
embryos at E10.5.
(B and D) 2D projections of 3D Imaris-
reconstructed z stacks through trunks of control
(B) and Sox9 null (D) embryos after whole mount
immunofluorescence staining for Foxa2 and Pdx1.
Although smaller, dorsal and ventral pancreatic
buds are present in E10.5 Sox9 null embryos
(D and D0). Fields demarcated by white dashed
boxes in (B) and (D) are shown at higher magnifi-
cation in (B0) and (D0), respectively. Only single-
channel Pdx1 signal is shown in (B0) and (D0).
(E–H00) Immunofluorescence staining of sections
through the pancreatic region of control Sox9fl/fl
(E–F00) and Sox9fl/fl;Foxa3-Cre (Sox9Dgut/Dgut;
G–H00) embryos at E9.5. Sox9 is efficiently deleted
in dorsal (G0 and G00) and ventral (H0 and H00)
pancreatic buds ofSox9Dgut/Dgut embryos. Dashed
line in (G0 ) and (H0 ) demarcates the Pdx1+ domain.
(I–T) X-Gal staining for b-galactosidase expressed
from the Pdx1LacZko allele in E10.5 and E12.5
embryos carrying combinations of mutant alleles
for Pdx1 and Sox9. With increasing loss of Sox9
dosage on either Pdx1-heterozygous (I–N) or Pdx1
null (O–T) backgrounds, dorsal and ventral
pancreatic buds become increasingly hypoplastic.
In Pdx1/;Sox9Dgut/Dgut embryos (S and T),
pancreatic buds are not discernible. Note the
reduced ventral pancreas in E12.5 compound
heterozygous mutants (L). Asterisks denote
absence of ventral pancreas.
(U)With decreasing dosage of functional Pdx1 and
Sox9 alleles, pancreatic morphogenesis becomes
increasingly perturbed.
dp, dorsal pancreas; vp, ventral pancreas; duo,
duodenum; stom, stomach; li, liver; bd, bile duct.
Scale bars represent 50 mm (E–H00), 70 mm (B, B0,
D, and D0), 200 mm (A and C), and 250 mm (I–T).Prox1 further revealed maintenance of their expression in em-
bryos lacking either Pdx1, Sox9, or both (Figures S1O–S1BB
and data not shown).
In contrast, expression of the pancreas-specific TF Ptf1a was
drastically reduced in Sox9Dgut/Dgut and Pdx1/;Sox9Dgut/Dgut
embryos (Figures S1CC–S1II), showing that Ptf1a expression
is Sox9-dependent. Albeit to a lesser extent, Ptf1a expression
was also diminished in Pdx1/ embryos (Figure S1HH). Like
Ptf1a, the TF Nkx6.1 is pancreas-specific and, together with
Ptf1a, governs the endocrine versus acinar cell fate choice
(Schaffer et al., 2010). Nkx6.1 was not detected in Pdx1/
and Pdx1/;Sox9Dgut/Dgut embryos and was reduced in
Sox9Dgut/Dgut embryos (Figures S1NN–S1PP). This confirms
earlier findings in Pdx1/ embryos (Pedersen et al., 2005)
and suggests that Pdx1 is dominant over Sox9 in regulating
Nkx6.1 expression. Together, our findings show that expres-
sion of the pancreas-restricted TFs Ptf1a and Nkx6.1 is under
the control of Pdx1 and Sox9, whereas the expression of
Foxa2, Mnx1, Onecut-1, Tcf2, Gata4, and Prox1 is Pdx1- and
Sox9-independent.CPDX1 and SOX9 Co-regulate Intestinal Cell Fate
Determinants
To define the mechanistic basis of the observed cooperativity
between Pdx1 and Sox9 in specifying the pancreatic fate, we
mapped where PDX1 and SOX9 bind in the genome to explore
synergy at the level of gene regulation. As the number of pancre-
atic progenitors in early mouse embryos is extremely limited, we
generated pancreatic progenitors from hESCs (Xie et al., 2013)
and performed chromatin immunoprecipitation and sequencing
(ChIP-seq) analysis for PDX1 and SOX9. We mapped 55,481
unique binding peaks for PDX1 and 9,767 unique peaks for
SOX9 (Figure 4A). PDX1 and SOX9 peaks exhibited surprisingly
limited overlap (Figure 4B), which was unexpected given that
lineage-determining TFs generally bind to cis-regulatory ele-
ments, in particular enhancers, as a collective unit (Spitz and
Furlong, 2012). To understand the basis for the limited overlap
in PDX1 and SOX9 binding sites, we analyzed PDX1 and SOX9
occupancy specifically at promoters and enhancers, using chro-
matin maps we recently generated based on histone modifica-
tions (Wang et al., 2015). This analysis revealed recruitment ofell Reports 13, 326–336, October 13, 2015 ª2015 The Authors 329
Figure 4. PDX1 and SOX9 Co-occupy
Pancreatic and Intestinal Genes
(A) Genome-wide distribution of PDX1 and SOX9
binding peaks within the human genome from
ChIP-seq analysis of hESC-derived pancreatic
progenitors.
(B) Venn diagram of the overlap between PDX1
binding peaks and SOX9 binding peaks (minimum
of 1-bp overlap).
(C) Venn diagram of the overlap between genes
bound by PDX1 and SOX9, showing 2,201 genes
to be co-bound by PDX1 and SOX9 (hypergeo-
metric analysis: p value = 4.33109).
(D) Gene ontology (GO) analysis of PDX1 and
SOX9 co-bound genes (defined as PDX1 and
SOX9 binding at enhancers and/or promoters
within a 200-kb window).
(E) Analysis of co-bound genes revealed that 82%
of the co-bound genes are expressed, and 18%
are not expressed in hESC-derived pancreatic
progenitors.
(F) ChIP-seq binding profiles (reads per million) for
PDX1, SOX9, and histone modifications
(H3K4me1, H3K27ac, H3K4me3, and H3K27me3)
at the PTF1A and CDX2 loci in hESC-derived
pancreatic progenitors. Enhancers were identified
based on presence of H3K27ac and H3K4me1
and absence of H3K3me3. Black boxes indicate
conserved regions in mice. kB, kilobases.both PDX1 and SOX9 to promoters, albeit to not entirely overlap-
ping sites (Figure S2A). Strikingly, and in stark contrast to PDX1,
there was little recruitment of SOX9 to enhancers (Figure S2B).
Other TFs with roles in early pancreatic development, such as
FOXA2, ONECUT-1, and TCF2, occupied enhancers together
with PDX1 (Figure S2B), consistent with TFs forming regulatory
collectives at transcriptional enhancers (Calo and Wysocka,
2013). Together, these findings show that SOX9 is predomi-
nantly recruited to promoter regions, while PDX1 and other early
pancreatic TFs co-occupy enhancers.
To relate PDX1 and SOX9 binding patterns to gene regulatory
functions, we used the Genomic Regions Enrichment of Annota-
tions Tool (GREAT) to predict putative target genes of PDX1-
bound enhancers and then cataloged genes with binding peaks
for PDX1 and SOX9 around transcriptional start sites and/or at
PDX1-bound enhancers. This analysis identified 2,201 PDX1
and SOX9 co-bound genes (Figure 4C; Table S1). Consistent
with the cooperative role of Pdx1 and Sox9 in pancreatic fate
determination, regulators of pancreatic development are PDX1
and SOX9 co-bound, exemplified by the TFs PTF1A, PAX6,
and NEUROG3 (Figures 4C and 4F). Interestingly, PDX1 and
SOX9 co-bound genes were enriched for Gene Ontology (GO)
categories associated with cell developmental processes,
including gut and liver development (Figure 4D). Occupancy
of hepatic genes by PDX1 and SOX9 provides a possible expla-330 Cell Reports 13, 326–336, October 13, 2015 ª2015 The Authorsnation for why hepatic genes are ectopi-
cally expressed in Pdx1- and Sox9-defi-
cient pancreatic buds (Seymour et al.,
2012). PDX1 and SOX9 co-bound genes
included several intestinal cell-fate-determining TFs, such as CDX2, ONECUT-2, and NKX6-3 (Fig-
ures 4C and 4F) (Dusing et al., 2010; Nelson et al., 2005;
Pedersen et al., 2005), suggesting a possible role for SOX9
and PDX1 in regulating these genes at the lineage bifurcation
of pancreas and gut. Eighteen percent of all PDX1 and SOX9
co-bound genes were not expressed in pancreatic progenitors
(Figure 4E), indicating that PDX1 and SOX9 could play a role in
gene silencing. Combined, these results suggest cooperative
roles for SOX9 and PDX1 in the regulation of pancreatic and in-
testinal genes.
Based on these findings, we predicted that decreased Pdx1
and Sox9 levels would induce ectopic activation of intestinal
genes in the pancreatic domain. To test this, we identified co-
regulated genes of both factors through transcriptional profiling
of pancreatic progenitors from embryos with reduced Pdx1 and
Sox9 gene dosage. Given that (1) both pancreatic buds are
virtually absent in Pdx1;Sox9 double-homozygous mutants and
(2) evidence of genetic interaction in compound Pdx1;Sox9
heterozygous mutants, we reasoned that mRNA profiling of pan-
creata from compound Pdx1;Sox9 heterozygous mutants versus
either single-heterozygous mutant could identify co-regulated
genes. Hence, we performed cDNAmicroarray profiling of dorsal
pancreatic epithelia from Pdx1+/, Pdx1+/;Sox9+/Dgut, and
Sox9+/Dgut littermatesatE12.5when theepithelium is still predom-
inantly composed of undifferentiated progenitor cells (Figure 5A).
Figure 5. Pdx1 and Sox9 Cooperatively
Silence Genes Encoding Intestinal Cell
Fate Regulators
(A) Illustration of the experimental strategy for
gene expression microarray analysis. The mRNA
profiles of E12.5 pancreata (n = 12 per genotype)
from (1) Pdx1+/ versus Pdx1+/;Sox9+/Dgut and (2)
Sox9+/Dgut versus Pdx1+/;Sox9+/Dgut littermates
were compared.
(B) A total of 3,337 and 4,486 genes were differ-
entially expressed between (1) and (2), respec-
tively. A total of 1,817 geneswere common to both
sets of significantly regulated genes (FDR < 0.05)
with the same sign of change (i.e., upregulated or
downregulated).
(C) Pdx1- and Sox9-co-regulated genes were
identified by cross-comparing mRNA profiles
of E12.5 pancreata (n = 12 per genotype) from
(1) Pdx1+/ versus Pdx1+/;Sox9+/Dgut and (2)
Sox9+/Dgut versus Pdx1+/;Sox9+/Dgut littermates.
A total of 1,817 genes (denoted by red pixels) were
common to both sets of significantly regulated
genes (FDR < 0.05) with the same sign of change.
(D) Gene ontology analysis of the 1,817 Pdx1- and
Sox9-co-regulated genes.
(E) The top 20 Pdx1- and Sox9-co-repressed
genes with the highest fold change.Comparison of gene expression profiles revealed significant
differences in the expression of 3,337 genes (false discovery
rate [FDR] < 0.05) between Pdx1+/;Sox9+/Dgut and Pdx1+/
pancreatic epithelia and 4,486 genes (FDR < 0.05) between
Pdx1+/;Sox9+/Dgut and Sox9+/Dgut epithelia (Figure 5B; Tables
S2 and S3). We then performed a cross-comparison of these
two datasets in order to identify Pdx1- and Sox9-co-regulated
genes. A total of 1,817 genes were common to both sets of
significantly regulated genes with the same sign of change
(i.e., upregulated or downregulated) (Figures 5B and 5C: co-
regulated genes are denoted by red pixels in Figure 5C; Table
S4) and associated with the GO term foregut morphogenesis
(Figure 5D; Table S5). Intriguingly, among the top 20 Pdx1- and
Sox9-co-repressed genes with the highest fold change were
several genes encoding intestinal cell fate regulators, including
Cdx2, Onecut-2, and Nkx6.3 (Figure 5E), which also showedCell Reports 13, 326–336,co-recruitment of PDX1 and SOX9 to their
regulatory regions (Figures 4C and 4F;
Table S1). These intestinal markers were
all upregulated in pancreatic epithelia
from compound Pdx1;Sox9 heterozy-
gous mutants, suggesting a synergistic
and direct role for Pdx1 and Sox9 in re-
pressing genes encoding intestinal line-
age regulators.
Pdx1 and Sox9 Jointly Control the
Pancreatic versus Intestinal Cell
Fate Choice
To determine whether Pdx1 and Sox9
indeed control the fate decision between
pancreas and intestine, we analyzed theexpression of the intestinal marker Cdx2 in the pancreatic region
of embryos carrying various combinations of the Pdx1 null and
Sox9Dgut alleles. In control embryos at E10.5, cells of the dorsal
pancreatic bud can be identified by high levels of Pdx1 expres-
sion, whereas prospective duodenal cells express the intestinal
marker Cdx2 (Figures 6A–6A00 and 6P). At the duodenal-pancre-
atic junction, the Pdx1high domain forms a boundary with the
Cdx2+ domain; only a few Pdx1high cells express Cdx2 (Figures
6A–6A00 and 6P; note, duodenal precursors express low levels
of Pdx1; Fukuda et al., 2006). As in control embryos, the Pdx1high
and Cdx2+ domains were distinct in embryos deficient for a sin-
gle copy of either Pdx1 or Sox9, compound Pdx1;Sox9 heterozy-
gous mutant embryos, and Pdx1 or Sox9 single-homozygous
mutants (Figures 6B–6F00). In stark contrast, immunofluores-
cence staining for the truncated Pdx1 protein and Cdx2 in em-
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revealed extensive overlap between the Cdx2+ and Pdx1+ do-
mains (Figures 6G–6G00, and 6P). Thus, the presence of either
Pdx1 or Sox9 is sufficient to repress the intestinal marker Cdx2
in the pancreatic domain, whereas loss of both Pdx1 and Sox9
results in ectopic Cdx2 expression. In contrast, combined
Pdx1 and Sox9 deletion did not result in ectopic expression of
the stomach marker Sox2 in the Pdx1+ domain (Figures S3A–
S3D00), showing that Pdx1 and Sox9 cooperatively repress intes-
tinal, but not anterior, foregut markers.
To directly test whether Pdx1 and Sox9 are sufficient to
repress the intestinal fate in vivo, we forcibly expressed Sox9
in Pdx1-expressing foregut progenitor cells, using a Pdx1-driven
tetracycline transactivator mouse (Pdx1tTA) and a single copy,
tetracycline-regulated Sox9 transgene (mCherry-tetO-Sox9) in-
serted into the disabled Rosa26 locus (Rosa26mCherry-tetO-Sox9)
(Figure S3E). In this system, Sox9 and the mCherry reporter
gene are expressed in the Pdx1+ domain in the absence of doxy-
cycline; administration of doxycycline suppresses transgene
expression. In Pdx1tTA;Rosa26mCherry-tetO-Sox9 (Sox9GOF) em-
bryos never exposed to doxycycline, Sox9 expression was
enforced in Pdx1+ cells of the pancreatic buds, antral stomach,
and duodenum (Figures S3F–S3G00). In control embryos, Sox9
is detectable in the antral stomach and duodenum, but at
much lower levels than in the pancreas (Figures S3F–S3F00).
Formation of the pancreatic buds and gross gut morphology
in Sox9GOF embryos were comparable to controls (Figures
S3H–S3K).
Consistent with previous observations that Sox9 reinforces
Pdx1 expression (Dubois et al., 2011; Seymour et al., 2012),
ectopic Sox9 expression resulted in increased Pdx1 staining in-
tensity in the duodenal domain (Figures 6H–6I00), thus creating an
extra-pancreatic Sox9high/Pdx1high domain. In this domain, we
observed reduced expression of the intestinal markers Cdx2
and Onecut-2, showing that the concerted activities of Pdx1
and Sox9 are sufficient to repress intestinal cell fate determi-
nants (Figures 6J–6M00 and 6P). Notably, despite induction of a
Pdx1high state and repression of intestinal markers in Sox9GOF
embryos, Sox9 overexpression failed to induce Ptf1a in intestinal
progenitors (Figures 6N–6O00). Previous work has shown that
Ptf1a misexpression in the gut tube induces ectopic pancreas
formation (Willet et al., 2014). Consistent with the lack of Ptf1a in-
duction, an ectopic pancreatic budwas not observed in Sox9GOF
embryos (Figures 6N–6O00). Combined, these results show that a
Sox9high/Pdx1high state prevents foregut endoderm progenitor
cells from adopting intestinal lineage identity.
DISCUSSION
In this study, we uncover a cooperative role for Pdx1 and Sox9 in
governing the lineage choice between pancreas and intestine.
Our data suggest a model whereby Pdx1 and Sox9 establish
pancreatic lineage identity by excluding intestinal lineage-
restricted TFs, such as Cdx2, from foregut endoderm progenitor
cells (Figure 6Q). Our work further shows that the concerted
activities of Pdx1 and Sox9 induce pancreatic differentiation pro-
grams through regulation of the pancreas-specific TFs Ptf1a and
Nkx6.1. Interestingly, although the TFs Foxa2, Mnx1, Onecut-1,
Tcf2, Gata4, and Prox1 are also important in early pancreas332 Cell Reports 13, 326–336, October 13, 2015 ª2015 The Authorsdevelopment (Seymour and Sander, 2011; Shih et al., 2013), their
expression was not affected by combined Pdx1 and Sox9 dele-
tion. These findings suggest that Sox9 and Pdx1 together are
essential for driving pancreatic gene expression. The pancreatic
program is reinforced by both positive autoregulation of Pdx1
(Marshak et al., 2000) and Sox9 (Lynn et al., 2007; Mead et al.,
2013) and a positive cross-regulatory loop between Pdx1 and
Sox9 (Dubois et al., 2011; Seymour et al., 2012). Themutual rein-
forcement of expression between Pdx1 and Sox9 appears to be
direct, as PDX1 occupied SOX9 regulatory sequences and vice
versa (Figure S2C). Early pancreatic TFs induce a Notchhigh state
that is important for maintaining the pancreatic state (Ahnfelt-
Rønne et al., 2012; Jensen et al., 2000). For example, Sox9
and Ptf1a both promote expression of the Notch effector Hes1
in the early pancreas, and Hes1 in turn reinforces Ptf1a expres-
sion (Ahnfelt-Rønne et al., 2012).
Previous studies have shown that a subset of normally
pancreas-fated cells adopt intestinal identity in Ptf1a null
mutant mice (Kawaguchi et al., 2002). This invokes the question
of how Pdx1, Sox9, and Ptf1a contribute to the gene regulatory
network that establishes pancreatic identity and prevents
foregut progenitors from becoming intestinal cells. Together
with published observations, findings reported here identify
Sox9 and Pdx1 as lying upstream of Ptf1a in the transcriptional
regulatory cascade effecting pancreas induction (Figure 6Q).
Several observations support this conclusion. First, combined
deletion of Pdx1 and Ptf1a phenocopies the effects of Pdx1
deletion, arguing that Pdx1 is required prior to Ptf1a in pancre-
atic specification (Burlison et al., 2008). Second, we show that
Ptf1a is not expressed in the absence of Sox9 (Figure S1GG),
whereas Sox9 and Pdx1 induction do not depend on Ptf1a
(Seymour et al., 2012). We note that Sox9 regulates Ptf1a
only during pancreas specification, but not later in pancreas
development, when the Sox9 and Ptf1a expression domains
are distinct (Shih et al., 2012).
It is important to consider that after combined inactivation of
Pdx1 and Ptf1a in mice or Xenopus, the dorsal pancreatic bud
still forms and early pancreatic genes are activated (Afelik
et al., 2006; Burlison et al., 2008). Furthermore, we found that
despite intestinal fate conversion of some Ptf1a-deficient cells
(Kawaguchi et al., 2002), Cdx2 remains excluded from the
pancreatic domain in Ptf1a null mutants (data not shown). These
findings suggest that the pancreatic-to-intestinal boundary is still
established in the absence of Pdx1 and Ptf1a. In contrast, we
show that combined deletion of Sox9 and Pdx1 leads to misspe-
cification of progenitors in the foregut endoderm, converting the
pancreatic domain into a Cdx2-expressing intestinal domain
(Figure 6G). Moreover, ectopic expression of Sox9 in duodenal
precursors was sufficient to induce Pdx1 and repress Cdx2 (Fig-
ures 6I and 6K). These findings identify Sox9 as a critical early
component of the gene regulatory network that governs both
the activation of pancreatic genes and the repression of intesti-
nal genes. Consistent with this notion, we found that SOX9 oc-
cupies genomic regions near genes required for early pancreatic
development (i.e., PTF1A) as well as intestinal development (i.e.,
CDX2). Mechanistically, our data imply that Sox9 can function as
either a transcriptional activator or repressor. Such a dual role for
Sox9 is consistent with its ability to recruit both transcriptional
(legend on next page)
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coactivators and corepressors (Lee et al., 2012; Leung et al.,
2011).
Of interest is our finding that SOX9 and PDX1 bind to distinct
cis-regulatory elements within the genome. While PDX1,
FOXA2, ONECUT-1, and TCF2 collectively occupy enhancers,
SOX9 was predominantly detected in promoter regions, sug-
gesting a unique role for SOX9 in the regulation of gene expres-
sion. This observation could be relevant to gene regulatory
mechanisms in multiple contexts, as Sox9 controls cell lineage
decisions in several tissues, including gonad, lung, and kidney
(Reginensi et al., 2011; Rockich et al., 2013; Sekido and Lovell-
Badge, 2008). A future direction will be to test whether pro-
moter-specific recruitment of Sox9 is also seen in other tissues
and to determine how Sox9 deposition at promoters evokes
cooperative effects with tissue-specific TFs bound to enhancers.EXPERIMENTAL PROCEDURES
Mouse Strains
All animal experiments described herein were approved by the University of
California San Diego Institutional Animal Care and Use Committees. The
following mouse strains have been previously described: Sox9flox (Kist et al.,
2002), Pdx1LacZko (herein designated Pdx1) (Offield et al., 1996), Foxa3-Cre
(Lee et al., 2005), Sox9-CreER (Kopp et al., 2011), Pdx1-CreER (Gu et al.,
2002), Prm1-Cre (O’Gorman et al., 1997), Zp3-Cre (de Vries et al., 2000),
Pdx1tTA (Holland et al., 2002), and R26mT/mG (Muzumdar et al., 2007). To
generate Sox9 null mice, germline recombination of the Sox9-flox allele was
employed as previously described (Akiyama et al., 2004). Briefly, Sox9fl/+
mice were bred to carry either the oocyte-specific Zp3-Cre (de Vries et al.,
2000) or the spermatid-specific Prm1-Cre (O’Gorman et al., 1997) transgenes.
One Sox9 allele was deleted in the oocytes or spermatids of Zp3-Cre; or
Prm1-Cre;Sox9fl/+ mice, respectively; these mice were then crossed to obtain
Sox9 null embryos. To generate Rosa26mCherry-tetO-Sox9 mice, mouse Sox9
coding sequences with MluI and NheI restriction sites on the 50 and 30
ends were generated from E15.5 pancreas by linker-primer PCR. The PCR
product was then cloned into MluI and NheI sites of pBR322-hygro-ptight-
mcherry, screened for orientation, and confirmed for bidirectionality (primers:
Sox9-F MluI, 50-tcacgcgtATGAATCTCCTGGACCCCTT-30; Sox9-R NheI, 50-
ggctagcTCAGGGTCTGGTGAGCTGTGT-30 ). The bidirectional mCherry-tetO-
Sox9 gene was inserted as a single copy transgene into a functionally disabled
Rosa26 gene locus using recombinase-mediated cassette exchange as previ-
ously described (Chen et al., 2011; Long et al., 2004). Mice bearing the
Rosa26mCherry-tetO-Sox9 allele were obtained after blastocyst microinjections,
chimera matings, and FlpE-mediated removal of an FRT-flanked hygromycin
resistance cassette.
A single dose of 2 mg/40 g body weight tamoxifen (Sigma) dissolved at
10 mg/ml in corn oil was administered by intraperitoneal injection. For eachFigure 6. Pdx1 and Sox9 Are Necessary and Sufficient to Repress the
(A–G) Immunofluorescence analysis for Pdx1 and Cdx2 on E10.5 embryos ca
Pdx1;Sox9 heterozygous mutant or Pdx1 or Sox9 single-homozygous mutant emb
the Pdx1high dorsal pancreas (A–F). In Pdx1/;Sox9Dgut/Dgut embryos, a duodenal
a broad domain (arrows in G00).
(H–O) Immunofluorescence staining of sections from Sox9GOF and control litterm
(Oc2; L and M) in mCherry+ duodenal precursors in Sox9GOF mice. Pdx1 is upreg
Sox9GOF embryos.
Fields demarcated by dashed boxes in (A)–(O) are shown at higher magnification
(P) Summary of the phenotypes observed after combined Pdx1 and Sox9 deletio
(Q) Graphical model summary. Our data support a model whereby Pdx1 and S
transcription factors Nkx6.1 and Ptf1a and repressing the duodenal transcription
pancreatic fate choice. Repression of Sox9 by Cdx2 creates bistability of the fat
dp, dorsal pancreatic bud; vp, ventral pancreatic bud; duo, duodenum; stom, st
334 Cell Reports 13, 326–336, October 13, 2015 ª2015 The Authorsexperiment, a minimum of three embryos per genotype was analyzed. Midday
on the day of vaginal plug appearance was considered E0.5.
Analysis of ChIP-Seq Data
Raw Illumina sequencing reads were mapped to reference human genomic
database (version hg18) using Bowtie (version 1.1.0, http://bowtie-bio.
sourceforge.net/index.shtml) to generate sam files. Sam files were subse-
quently converted to tag directories using HOMER (http://homer.salk.edu/
homer/ngs/index.html). The ChIP-seq peak, peak distribution, and gene an-
notations were also annotated by HOMER analysis. Input sequencing data
were used to normalize background reads for peak calling. Overlapping
peaks were determined using the table browser function on the University
of California Santa Cruz (UCSC) Genome Browser website, with minimum
of 1-bp overlap. A 200-kb window was used to identify genes associated
with the peaks.
Transcription factor binding to a promoter was determined by presence of a
ChIP-seq peak within 20-kb upstream and 5-kb downstream of a transcrip-
tional start site (TSS) of an annotated gene. Transcription factor binding to
an enhancer was determined based on a minimum of 1-bp overlap between
a transcription factor ChIP-seq peak and a predicted enhancer (defined as ±
500 bp from the center of the enhancer using the enhancer prediction tool; Ra-
jagopal et al., 2013). We assigned PDX1-bound enhancers to nearest genes
using GREAT (version 2.0, http://bejerano.stanford.edu/great/public/html/)
with a basal plus 200-kb extension rule setting. In Figures 4C–4E, PDX1-bound
genes were defined as genes with PDX1 binding at either promoters or en-
hancers corresponding to the gene. Since SOX9 did not exhibit significant
enrichment at enhancers, SOX9-bound genes were defined as genes with
SOX9 binding at promoters. Conserved regions were identified using the vista
point tool comparing human to mouse (Frazer et al., 2004).
Gene ontology analysis was performed using the web tool DAVID Functional
Annotation Bioinformatics Database (http://david.abcc.ncifcrf.gov/home.jsp)
(Huang et al., 2009). The complete set of all RefSeq genes was used as a
background.
ChIP-seq data for FOXA2, TCF2, and ONECUT-1 in hESC-derived pancre-
atic progenitors have been previously described (Weedon et al., 2014).
Principal Component Analysis
The quality of the RNA sequencing data was analyzed using the FastQC
v0.10.1 software. Once the samples passed quality control, they were aligned
to the hg19 genome using RNA-Star 2.3.0e, with the parameters set to default.
After alignment, Sailfish 0.6.3 and Cufflinks 2.2.0 were used to determine gene
expression values. Datasets incorporating multivariate sequencing informa-
tion (commonly gene expression values or splicing scores) were analyzed
via the dimensionality reduction method principal component analysis (PCA)
with the intention of uncovering features of the data that can explain variation
within the dataset and as a visual summary of the sample data. The data were
stored in pandas dataframes (pandas Python package v0.14.1) and visualized
using Matplotlib v0.13.
A detailed description of all methods is available in the Supplemental Exper-
imental Procedures.Intestinal Lineage Choice
rrying various combinations of Pdx1 and Sox9 mutant alleles. In compound
ryos, Cdx2 expression is restricted to duodenal precursors and excluded from
-pancreatic junction is not discernible, and Pdx1 and Cdx2 are co-expressed in
ates shows repression of the intestinal markers Cdx2 (J and K) and Onecut-2
ulated (H and I), but Ptf1a is not induced (N and O) in duodenal precursors in
in (A0)–(O00).
n or Sox9 overexpression.
ox9 cooperatively specify the pancreatic lineage by inducing the pancreatic
factor Cdx2. A positive regulatory loop between Pdx1 and Sox9 maintains the
e choice (Gao et al., 2009).
omach. Scale bar represents 50 mm.
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